dc.contributor.author
Ehlers, Lisa
dc.contributor.author
Rolfes, Elisabeth
dc.contributor.author
Lieber, Mareike
dc.contributor.author
Müller, Dominik
dc.contributor.author
Lainka, Elke
dc.contributor.author
Gohar, Faekah
dc.contributor.author
Klaus, Günter
dc.contributor.author
Girschick, Hermann
dc.contributor.author
Hörstermann, Jana
dc.contributor.author
Kümmerle-Deschner, Jasmin
dc.contributor.author
Brunner, Jürgen
dc.contributor.author
Palm-Beden, Katharina
dc.contributor.author
Tenbrock, Klaus
dc.contributor.author
von Wrangel, Lusine
dc.contributor.author
Faßhauer, Maria
dc.contributor.author
Blank, Norbert
dc.contributor.author
Trauzeddel, Ralf
dc.contributor.author
von Stuckrad, Anne Sae Lim
dc.contributor.author
Higgins, Sonja
dc.contributor.author
Welzel, Tatjana
dc.contributor.author
Lutz, Thomas
dc.contributor.author
Hentgen, Véronique
dc.contributor.author
Foell, Dirk
dc.contributor.author
Wittkowski, Helmut
dc.contributor.author
Kallinich, Tilmann
dc.date.accessioned
2025-09-17T12:15:33Z
dc.date.available
2025-09-17T12:15:33Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/49385
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-49107
dc.description.abstract
Background The objective of this initiative was to develop a treat-to-target (T2T) approach for the management of patients with Familial Mediterranean Fever (FMF), including the definition of a complex treatment target, and establish strategies that improve patient care and long-term outcome.MethodsAn initial set of statements as well as a flow chart visualising the proposed concept was developed. To adapt the preliminary statements to the current state of knowledge, a systematic literature search was performed and the modified statements were subject to a Delphi approach. To ensure the applicability of the statements in daily practice, an online survey was conducted among paediatric rheumatologists in Germany. In addition, data from the national AID-NET registry were analysed with respect to therapeutic response.ResultsThis T2T initiative yielded a total of 26 statements guiding FMF management with respect to diagnosis, treatment targets, treatment strategies and monitoring. The online survey identified cut-off values for inflammatory markers indicating treatment intensification and appropriate measures in case of colchicine intolerance or non-adherence. The analysis of data derived from the national AID-NET showed that colchicine therapy was successfully terminated in 61% of patients (27 out of 44) with heterozygous MEFV mutations. Multidimensional treatment targets incorporating objective and subjective reported outcome measures were developed. These provide the basis for stratifying patients into the following treatment paths: continue colchicine, persisting attacks / inflammation, colchicine intolerance, persisting arthritis, colchicine reduction and adjustment/reduction of biologics.ConclusionsThe proposed consensus treatment plan for the management of FMF incorporates multidimensional targets allowing transparent treatment decisions, which will promote personalised disease management and increase adherence to therapy.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Colchicine resistance
en
dc.subject
Disease activity
en
dc.subject
Familial Mediterranean Fever
en
dc.subject
interleukin-1 antagonists
en
dc.subject
Medication adherence
en
dc.subject
Treat-to-target
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Treat-to-target strategies for the management of familial Mediterranean Fever in children
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
108
dcterms.bibliographicCitation.doi
10.1186/s12969-023-00875-y
dcterms.bibliographicCitation.journaltitle
Pediatric Rheumatology
dcterms.bibliographicCitation.number
1
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.volume
21
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
37752496
dcterms.isPartOf.eissn
1546-0096